Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
lactobacillus reuteri (Puneet Laboratories)
- Development stage
- Unknown
- Lead developer
- Puneet Laboratories
- Modality
- Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Rutilac Drops is an oral probiotic supplement developed and marketed by Puneet Laboratories. The formulation contains *Lactobacillus reuteri* (100 million CFU per 5 drops), a beneficial bacterium that helps restore and maintain a healthy balance of gut microbiota. It is primarily indicated for infants and children to relieve infantile colic, gas, bloating, functional abdominal pain, and occasional diarrhea, while also supporting overall digestive comfort and immune health.
- Brand names
- Rutilac DropsRutilac Oral DropsRutilac Probiotic Drops
- Other names
- lactobacillus reuteri drops
02
Targets
AHR (Aryl hydrocarbon receptor)Intestinal mucins and mucosal glycansTLR2 (Toll-like Receptor 2)ADORA2A (Adenosine A₂A Receptor)HRH2 (Histamine H2 Receptor)
Beyond the preview
Go deeper on lactobacillus reuteri (Puneet Laboratories).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on lactobacillus reuteri (Puneet Laboratories).